Pharmiva AB/News/BioStock Investor Meeting: Pharmiva presents

BioStock Investor Meeting: Pharmiva presents

19 September 2022 - 08:27

At last week’s BioStock Investor Meeting, femtech company Pharmiva was first out to present. CEO Anna Linton talked about Pharmiva’s product against bacterial vaginosis, Vernivia, which was launched in Sweden at the end of 2021. Linton also elaborated on the company’s expansion strategy and the current rights issue that will support a global launch.

See the presentation at biostock.se:

https://www.biostock.se/en/2022/09/biostock-investor-meeting-pharmiva-presents/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Provided by: Cision

Pharmiva AB

Pharmiva is a medical technology company. It develops innovative antibiotic-free medical products in order to improve vaginal health....

Learn more about company

Related news

30.05.2023

Qlife Holding AB

Qlife announces the last day for trading in BTU and the first day for trading in warrants series TO 3

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICA...

30.05.2023

AegirBio AB

Kallelse till årsstämma i AegirBio AB (publ)

vara upptagen som aktieägare i den av Euroclear Sweden AB framställda aktieboken avseende förhållanden på avstämningsdagen som är den 21 juni 2023; och anmäla sig till stämman senast den 26 juni 2023. Anmälan görs per post till AegirBio AB...

30.05.2023

AegirBio AB

AegirBio appoints new CEO

Marco Witteveen has a degree within International Business from HU University of Applied Sciences Utrecht, an MBA within Sales Management and an MBA within Strategic Marketing. Marco Witteveen has previously had multiple different roles in Med Tech and diagnostic companies, respectively, including i...

30.05.2023

AegirBio AB

AegirBio utser ny VD

Marco Witteveen har en examen inom International Business från HU University of Applied Sciences Utrecht, en MBA inom Sales Management samt en MBA inom Strategic Marketing. Marco Witteveen har tidigare innehaft flera olika roller i Med Tech- respektive diagnostikföretag, bland annat Vice President i...